Of the 473 adult cannabis users surveyed by the Centre for Addictions Research of British Columbia, more than 86 percent of respondents reported giving up one or more of the substances for pot, with the majority (80.6 percent) forgoing pharmaceuticals for the non-toxic alternative. Those under 40 were also more likely to substitute all three for cannabis, demonstrating its dynamic appeal for both recreational and medical purposes. People suffering from chronic pain might be particularly inclined to use cannabis instead of prescription medication in light of recent studies that establish its effectiveness at treating pain, improving the quality of patients' lives, and posing no risk of serious adverse side effects. But there are numerous studies that support the idea of marijuana as a safer, more effective alternative to dangerous, addictive pills for a range of illnesses. [Full article]

Crispr Therapeutics led gene-editing stocks lower after new studies published by Nature Medicine found that cells whose genomes are edited with the CRISPR-Cas9 technology have the potential to cause cancer, Stat News reports. Editing cells’ genomes with CRISPR-Cas9 might increase the risk that the altered cells, intended to treat disease, will trigger cancer, two studies published on Monday warn — a potential game-changer for the companies developing CRISPR-based therapies. [Full article]